| Staurosporine | IC50 | 216.8 [1], 1500.0 [2], 10000.0 [3] |
| Balanol | IC50 | 3500.0 [1], 7400.0 [2] |
| Balanol analog 4 | IC50 | 150.0 [1], 6800.0 [2] |
| Balanol analog 5 | IC50 | 22000.0 [1] |
| 3-(3,4-Dichlorophenyl)-4-(6-iodo-1H-benzimidazol-2-yl)butanoic acid | IC50 | 12000.0 [1], 15900.0 [2], 18000.0 [3] |
| 4-[1-(4-Chlorophenyl)-3-tert-butyl-4,5-dihydro-1H-pyrazole-5-yl]phenol | IC50 | 3200.0 [1], 10700.0 [2], 26700.0 [3] |
| 4-[5-Tert-butyl-2-(4-chlorophenyl)-3,4-dihydropyrazol-3-yl]-2-chlorophenol | IC50 | 700.0 [1], 2900.0 [2], 14800.0 [3] |
| 4-[2-(3-Chlorophenyl)-3-(3-fluoro-4-hydroxyphenyl)-3,4-dihydropyrazol-5-yl]benzene-1,3-diol | IC50 | 100.0 [1], 1100.0 [2] |
| Isopropyl 2-amino-4-(3,4-dimethoxyphenyl)thiophene-3-carboxylate | IC50 | 6000.0 [1], 20000.0 [2], 35000.0 [3] |
| 4-[1-(4-Bromophenyl)-3-(2-thienyl)-4,5-dihydro-1H-pyrazole-5-yl]phenol | IC50 | 500.0 [1], 1000.0 [2] |
| 4-[5-Tert-butyl-2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-3-yl]phenol | IC50 | 2700.0 [1] |
| 4-[5-Tert-butyl-2-(3-chloro-4-fluorophenyl)-3,4-dihydropyrazol-3-yl]phenol | IC50 | 900.0 [1], 1900.0 [2] |
| 4-[5-Tert-butyl-2-(3,4-difluorophenyl)-3,4-dihydropyrazol-3-yl]phenol | IC50 | 500.0 [1], 900.0 [2] |
| 4-[5-Tert-butyl-2-(2,3,4-trifluorophenyl)-3,4-dihydropyrazol-3-yl]phenol | IC50 | 700.0 [1], 3100.0 [2] |
| 3-[5-Tert-butyl-2-(4-chlorophenyl)-3,4-dihydropyrazol-3-yl]phenol | IC50 | 2000.0 [1], 5300.0 [2] |
| 4-[5-Tert-butyl-2-(4-chlorophenyl)-3,4-dihydropyrazol-3-yl]-2-fluorophenol | IC50 | 3700.0 [1], 3800.0 [2] |
| 5-[5-Tert-butyl-2-(3-chlorophenyl)-3,4-dihydropyrazol-3-yl]-2-fluorophenol | IC50 | 300.0 [1], 2500.0 [2] |
| 2-[2-(4-Chlorophenyl)-3-(4-hydroxyphenyl)-3,4-dihydropyrazol-5-yl]phenol | IC50 | 1500.0 [1], 3100.0 [2] |
| 4-[2-(3-Chlorophenyl)-5-(2-hydroxyphenyl)-3,4-dihydropyrazol-3-yl]-2,6-difluorophenol | IC50 | 2500.0 [1], 11100.0 [2] |
| 4-[2-(3-Chlorophenyl)-5-(2-hydroxyphenyl)-3,4-dihydropyrazol-3-yl]-2-fluorophenol | IC50 | 2900.0 [1] |
| 4-[2-(3-Chlorophenyl)-5-(2-hydroxyphenyl)-3,4-dihydropyrazol-3-yl]-2,3-difluorophenol | IC50 | 1400.0 [1], 6600.0 [2] |
| 4-[5-Tert-butyl-2-(4-chlorophenyl)pyrazol-3-yl]-2-chlorophenol | IC50 | 3000.0 [1], 17400.0 [2] |
| Ethyl 2-amino-4-(benzo[d][1,3]dioxol-5-yl)thiophene-3-carboxylate | IC50 | 2000.0 [1] |
| 2-[2,6-Dihydroxy-4-[[2-[(4-hydroxybenzoyl)amino]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 50000.0 [1] |
| 3-(4-Chlorophenyl)-4-(6-iodo-1H-benzimidazol-2-yl)butanoic acid | IC50 | 33000.0 [1], 38000.0 [2] |
| 3-(4-Chlorophenyl)-4-(4,6-dichloro-1H-benzimidazol-2-yl)butanoic acid | IC50 | 14000.0 [1], 38000.0 [2] |
| 4-(6-Chloro-4-methyl-1H-benzimidazol-2-yl)-3-(4-chlorophenyl)butanoic acid | IC50 | 30000.0 [1], 55000.0 [2] |
| 4-(6-Chloro-1H-benzimidazol-2-yl)-3-(3,4-dichlorophenyl)butanoic acid | IC50 | 32000.0 [1], 39000.0 [2] |
| 4-(6-Iodo-1H-benzimidazol-2-yl)-3-(4-propylphenyl)butanoic acid | IC50 | 14000.0 [1], 33000.0 [2] |
| 2-[2,6-Dihydroxy-4-[(1R,2R)-2-[(4-hydroxybenzoyl)amino]cycloheptyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 150000.0 [1] |
| Balanol analog 3 | IC50 | 150000.0 [1] |
| 4-(6-Chloro-1H-benzimidazol-2-yl)-3-[4-chloro-3-(trifluoromethyl)phenyl]butanoic acid | IC50 | 28000.0 [1], 43000.0 [2] |
| 3-(4-Tert-butylphenyl)-4-(6-iodo-1H-benzimidazol-2-yl)butanoic acid | IC50 | 13000.0 [1], 23000.0 [2] |
| Ethyl 2-amino-4-(4-aminophenyl)thiophene-3-carboxylate | IC50 | 2000.0 [1] |
| Ethyl 2-amino-4-[4-(dimethylamino)phenyl]thiophene-3-carboxylate | IC50 | 800.0 [1], 1000.0 [2] |
| Benzyl 2-amino-4-(3,4-dimethoxyphenyl)thiophene-3-carboxylate | IC50 | 6000.0 [1] |
| (3-Methoxyphenyl)methyl 2-amino-4-(3,4-dimethoxyphenyl)thiophene-3-carboxylate | IC50 | 2000.0 [1], 5000.0 [2] |
| Ethyl 2-amino-4-(2-fluoro-4-methoxyphenyl)thiophene-3-carboxylate | IC50 | 4000.0 [1] |
| 4-[1-[4-(Trifluoromethyl)phenyl]-3-(2-thienyl)-4,5-dihydro-1H-pyrazole-5-yl]phenol | IC50 | 400.0 [1], 2900.0 [2] |
| 4-[2,3-Bis(4-chlorophenyl)-3,4-dihydropyrazol-5-yl]benzene-1,3-diol | IC50 | 4300.0 [1], 9700.0 [2] |
| 4-[2,3-Bis(3-chlorophenyl)-3,4-dihydropyrazol-5-yl]phenol | IC50 | 400.0 [1], 4100.0 [2] |
| 4-[2,3-Bis(4-chlorophenyl)-3,4-dihydropyrazol-5-yl]benzene-1,2-diol | IC50 | 100.0 [1], 800.0 [2] |
| 4-[2,3-Bis(4-chlorophenyl)-3,4-dihydropyrazol-5-yl]phenol | IC50 | 6200.0 [1], 20800.0 [2] |
| Dasatinib | IC50 | 50000.0 [1] |
| Bisindolylmaleimide i | IC50 | 5800.0 [1] |
| Enzastaurin | IC50 | 8000.0 [1] |
| Chir-99021 | IC50 | 10000.0 [1] |
| Ruboxistaurin | IC50 | 100000.0 [1] |
| Sotrastaurin | IC50 | 5400.0 [1] |
| Purvalanol B | IC50 | 100000.0 [1] |
| Purvalanol A | IC50 | 100000.0 [1] |
| Cfms Receptor Tyrosine Kinase Inhibitor | IC50 | 24000.0 [1] |
| Rac-syn-Balanol | IC50 | 3500.0 [1] |
| 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 100000.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| Methyl 2-amino-4-phenylthiophene-3-carboxylate | IC50 | 62000.0 [1] |
| (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 5000.0 [1] |
| CID 9957049 | IC50 | 10000.0 [1] |
| N-Cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-yl)methylamino)benzamide | IC50 | 40000.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 8300.0 [1] |
| 5-(3,4-Dimethoxyphenyl)-4-(1H-indol-5-ylamino)nicotinonitrile | IC50 | 50000.0 [1] |
| 4-(4-Methyl-1H-indol-5-ylamino)-5-(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)nicotinonitrile | IC50 | 100000.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 8333.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| 2,2-Dimethyl-7-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)-1-[(1R)-1-phenylethyl]-3H-quinazolin-4-one | IC50 | 1000.0 [1] |
| Meridianin E | IC50 | 4000.0 [1] |
| 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 8000.0 [1] |
| 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 8000.0 [1] |
| N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
| 3-(1-Methyl-1H-indol-3-yl)-4-(1-piperidin-4-yl-1H-indol-3-yl)-pyrrole-2,5-dione | IC50 | 4000.0 [1] |
| 2-Methoxy-4-[3-[4-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-6-yl]phenol | IC50 | 2.26 [1] |
| 2-[2,6-Dihydroxy-4-[3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 3500.0 [1] |
| [6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 50000.0 [1] |
| Unii-7N5LJ2Z26C | IC50 | 200.0 [1] |
| N-(7-Methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide | IC50 | 50000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 2-Anilino-7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethylpyrrolo[2,3-d]pyrimidin-6-one | IC50 | 10000.0 [1] |
| 4-(Cyclopentylamino)-2-[(2-methoxyphenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxopyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide | IC50 | 30000.0 [1] |
| 3-[1-(1-Benzylpiperidin-4-yl)indol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | IC50 | 100000.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3R,4R)-3-[(4-hydroxybenzoyl)amino]oxepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 150000.0 [1] |
| 3-[(6-Benzoyl-5-Methylpyrrolo[2,1-F][1,2,4]triazin-4-Yl)amino]-N-Cyclopropyl-4-Methylbenzamide | IC50 | 25000.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3S,4R)-3-[(4-hydroxybenzoyl)amino]thiepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 121000.0 [1] |
| 2-[2,6-Dihydroxy-4-[[(3R,4R)-3-[(4-hydroxybenzoyl)amino]-1-azabicyclo[3.2.2]nonan-4-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 22500.0 [1] |
| 3-[1-[3-(Dimethylamino)propyl]indazol-3-yl]-4-(1-naphthalen-1-ylindol-3-yl)pyrrole-2,5-dione | IC50 | 10000.0 [1] |
| 3-[1-[3-(Dimethylamino)propyl]indazol-3-yl]-4-(1-pyridin-3-ylindol-3-yl)pyrrole-2,5-dione | IC50 | 4400.0 [1] |
| 3-[1-(1-Benzothiophen-3-yl)indol-3-yl]-4-[1-[3-(dimethylamino)propyl]indazol-3-yl]pyrrole-2,5-dione | IC50 | 10000.0 [1] |
| 3-[1-[3-(Dimethylamino)propyl]indazol-3-yl]-4-(1-naphthalen-2-ylindol-3-yl)pyrrole-2,5-dione | IC50 | 6200.0 [1] |
| 3-[1-[3-(Dimethylamino)propyl]indazol-3-yl]-4-(1-quinolin-3-ylindol-3-yl)pyrrole-2,5-dione | IC50 | 5700.0 [1] |
| 2-[4-[(1R,2R,4S)-4-(Aminomethyl)-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonyl-2,6-dihydroxybenzoyl]-3-hydroxybenzoic acid | IC50 | 2800.0 [1] |
| (18S)-18-(Hydroxymethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 8700.0 [1] |
| 2-[2,6-Dihydroxy-4-[(1R,2R,4S)-2-[(4-hydroxybenzoyl)amino]-4-(hydroxymethyl)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 39000.0 [1] |
| 2-[4-[(1R,2R,4R)-4-Amino-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonyl-2,6-dihydroxybenzoyl]-3-hydroxybenzoic acid | IC50 | 1200.0 [1] |
| 2-[2,6-Dihydroxy-4-[(1R,2R,4R)-4-hydroxy-2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 13000.0 [1] |
| (18S)-18-(Aminomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | IC50 | 44000.0 [1] |
| 2-[2,6-Dihydroxy-4-[(1R,2R,4R)-2-[(4-hydroxybenzoyl)amino]-4-(hydroxymethyl)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 34000.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3S,4S)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 150000.0 [1] |
| 2-[2,6-Dihydroxy-4-[(3S,4R)-3-[(4-hydroxybenzoyl)amino]-1,1-dioxothiepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 150000.0 [1] |
| N-[[(18S)-3,5-Dioxo-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaen-18-yl]methyl]benzenesulfonamide | IC50 | 5000.0 [1] |